{"id":"https://openalex.org/W2333360587","doi":"https://doi.org/10.1016/s1096-6374(12)60104-x","title":"P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity","display_name":"P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity","publication_year":2012,"publication_date":"2012-10-01","ids":{"openalex":"https://openalex.org/W2333360587","doi":"https://doi.org/10.1016/s1096-6374(12)60104-x","mag":"2333360587"},"language":"en","primary_location":{"id":"doi:10.1016/s1096-6374(12)60104-x","doi":"https://doi.org/10.1016/s1096-6374(12)60104-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1096-6374(12)60104-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210169230","display_name":"Growth Hormone & IGF Research","issn_l":"1096-6374","issn":["1096-6374","1532-2238"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Growth Hormone &amp; IGF Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008737548","display_name":"Liesbeth Bieghs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Bieghs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091159768","display_name":"Ken Maes","orcid":"https://orcid.org/0000-0001-8906-2790","observed_orcids":["https://orcid.org/0000-0001-8906-2790"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Maes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003841688","display_name":"Els Van Valckenborgh","orcid":"https://orcid.org/0000-0002-8427-2411","observed_orcids":["https://orcid.org/0000-0002-8427-2411","https://orcid.org/0009-0008-1271-5245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Van Valckenborgh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003658156","display_name":"Eline Menu","orcid":"https://orcid.org/0000-0002-0805-6581","observed_orcids":["https://orcid.org/0000-0002-0805-6581"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Menu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066949744","display_name":"Hans Erik Johnsen","orcid":"https://orcid.org/0000-0001-8253-2913","observed_orcids":["https://orcid.org/0000-0001-8253-2913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.E. Johnsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048834813","display_name":"Mette Nyegaard","orcid":"https://orcid.org/0000-0003-4973-8543","observed_orcids":["https://orcid.org/0000-0003-4973-8543","https://orcid.org/0000-0002-2967-6624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Nyegaard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005955450","display_name":"Michael Toft Overgaard","orcid":"https://orcid.org/0000-0002-1423-2481","observed_orcids":["https://orcid.org/0000-0002-1423-2481"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.T. Overgaard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085005741","display_name":"O. Larson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. Larson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052542248","display_name":"Helena Jernberg\u2010Wiklund","orcid":"https://orcid.org/0000-0002-9319-7986","observed_orcids":["https://orcid.org/0000-0002-9319-7986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Jernberg-Wiklund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014026887","display_name":"Karin Vanderkerken","orcid":"https://orcid.org/0000-0002-2137-7179","observed_orcids":["https://orcid.org/0000-0002-2137-7179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Vanderkerken","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027619485","display_name":"Elke De Bruyne","orcid":"https://orcid.org/0000-0003-4012-4617","observed_orcids":["https://orcid.org/0000-0003-4012-4617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. De Bruyne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S40","last_page":"S40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/picropodophyllin","display_name":"picropodophyllin","score":0.9200000166893005},{"id":"https://openalex.org/keywords/abt-737","display_name":"ABT-737","score":0.9459999799728394},{"id":"https://openalex.org/keywords/igf-1-receptor-inhibition","display_name":"IGF-1 receptor inhibition","score":0.8270000219345093},{"id":"https://openalex.org/keywords/bh3-mimetics","display_name":"BH3 mimetics","score":0.8939999938011169},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.7580000162124634},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.953000009059906},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.34299999475479126}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5574008822441101},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5357944369316101},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43842169642448425},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3402327299118042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28632164001464844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1096-6374(12)60104-x","doi":"https://doi.org/10.1016/s1096-6374(12)60104-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1096-6374(12)60104-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210169230","display_name":"Growth Hormone & IGF Research","issn_l":"1096-6374","issn":["1096-6374","1532-2238"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Growth Hormone &amp; IGF Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2739682454","https://openalex.org/W3023596299","https://openalex.org/W6987525246","https://openalex.org/W3130107181","https://openalex.org/W2557672060","https://openalex.org/W2130621327","https://openalex.org/W7097421315","https://openalex.org/W2156653164","https://openalex.org/W3128235682","https://openalex.org/W2114321011"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
